State Street Corp Evolus, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Evolus, Inc. stock. As of the latest transaction made, State Street Corp holds 1,032,568 shares of EOLS stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,032,568
Previous 1,026,374
0.6%
Holding current value
$11.3 Million
Previous $10.8 Million
33.76%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding EOLS
# of Institutions
173Shares Held
47MCall Options Held
720KPut Options Held
532K-
Perceptive Advisors LLC New York, NY5.75MShares$62.9 Million1.69% of portfolio
-
Tang Capital Management LLC San Diego, CA4.15MShares$45.3 Million7.07% of portfolio
-
Black Rock Inc. New York, NY3.26MShares$35.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.04MShares$33.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$31.8 Million2.62% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $613M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...